Developing Next- Generation Immunostimulatory Dual Payload ADCs to Enhance Therapeutic Index & Tackle Patient Resistance
- Exploring targeted delivery of cytotoxins and immune agonists simultaneously
- Explaining how dual mechanisms enable direct tumor cell killing and activation of anti-tumor immunity
- Demonstrating immunostimulatory ADC enhanced efficacy and therapeutic index